Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

Genospace tapped for precision medicine initiative
December 2015
SHARING OPTIONS:

CAMBRIDGE, Mass.—Precision medicine software company Genospace recently announced that Sequence Bioinformatics Inc. and the government of Newfoundland and Labrador have chosen Genospace Population Analytics to support a new precision medicine initiative. The goal is to engage 100,000 individuals in a large-scale initiative to capture a large body of genomic and phenotypic data, with the information and analysis to be made available to a number of organizations to improve patient care. Genospace Population Analytics provides a comprehensive software platform for the initiative, as well as valuable translational medicine capabilities.
 
“The Newfoundland and Labrador population is a unique resource for genetic investigation of complex diseases,” said Mick Correll, co-founder and CEO of Genospace. “The province’s collaboration with Sequence Bio takes a community-based approach to apply the latest genomic technologies to advance data-driven precision medicine. We are excited to power this important initiative.”

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.